TrialMedical oncology (Northwood, London, England)2011

A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results.

Jaime Coronel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.